REG - Marlowe PLC - Issue of Equity and Total Voting Rights

MarloweAnnouncement

01/04/2021 16:45

RNS Number : 3874U
  
Marlowe PLC
  
01 April 2021
  
 

1 April 2021
 
Marlowe plc 
("Marlowe" or the "Group")
 
Issue of Equity and Total Voting Rights
 
Marlowe plc ("Marlowe", the "Group" or the "Company"), the UK leader in business-critical services and software which assure safety and regulatory compliance, announces that, following the achievement of profit targets in respect of the Group's 2019 acquisition of Law At Work (Holdings) Limited (the "Acquisition"), final contingent consideration of £4.3 million, including the issue of 153,923 new ordinary shares of 50 pence each in the Group (the "New Ordinary Shares") at an effective issue price of 717 pence per ordinary share, will be payable by the Group in respect of the Acquisition. 
 
Application has been made for the 153,923 New Ordinary Shares to be admitted to trading on AIM ("Admission"). The New Ordinary Shares will rank pari passu with the Group's existing ordinary shares, and it is expected that Admission will occur at 8.00 a.m. on 9 April 2021.
 
Following Admission, the Company's issued ordinary share capital will comprise 77,123,772 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 77,123,772.
 
The above figure of 77,123,772 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
For further information:
 



Marlowe plc


www.marloweplc.com










 




Alex Dacre, Chief Executive


Tel: +44 (0) 203 813 8498










 




Mark Adams, Group Finance Director


IR@marloweplc.com










 




















 




Cenkos Securities plc (Nominated Adviser and Joint Broker)










 




Nicholas Wells


Tel: +44 (0)20 7397 8900












Ben Jeynes














 
















 




Berenberg (Joint Broker)














 




Ben Wright










 




Mark Whitmore


Tel: +44 (0)20 3207 7800






 
















 




FTI Consulting










 




Nick Hasell










 




Alex Le May


Tel: +44 (0)20 3727 1340






 
















 













 
About Marlowe plc
Marlowe is a UK leader in business critical services and software which assure safety and regulatory compliance. The Group was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services. It is focused on health & safety, compliance software, employment law & HR compliance, fire safety, security, water treatment & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides services to over 15% of Britain's commercial premises and is increasingly attractive to customers who require a single outsourced, nationwide, provider of a comprehensive range of regulated compliance and safety services. Our customers can be found in most office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
IOEIBMATMTJMBLB